213 related articles for article (PubMed ID: 37125190)
1. Antidepressants amitriptyline, fluoxetine, and traditional Chinese medicine Xiaoyaosan caused alterations in gut DNA virome composition and function in rats exposed chronic unpredictable mild stress.
Li J; Qu W; Hu C; Liu Z; Yan H
Front Microbiol; 2023; 14():1132403. PubMed ID: 37125190
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress.
Zhang W; Qu W; Wang H; Yan H
Transl Psychiatry; 2021 Feb; 11(1):131. PubMed ID: 33602895
[TBL] [Abstract][Full Text] [Related]
3. Anti-depressive effects of Xiaoyaosan, Shugan and Jianpi herbal treatments: Role on the gut microbiome of CUMS rats.
Liu X; Lv M; Wang Y; Qu P; Li S; Yu Z; Qin X
Phytomedicine; 2021 Jul; 87():153581. PubMed ID: 34091149
[TBL] [Abstract][Full Text] [Related]
4. Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice.
Liu Y; Ding XF; Wang XX; Zou XJ; Li XJ; Liu YY; Li J; Qian XY; Chen JX
BMC Complement Altern Med; 2019 Aug; 19(1):215. PubMed ID: 31412844
[TBL] [Abstract][Full Text] [Related]
5. A combination of cecum microbiome and metabolome in CUMS depressed rats reveals the antidepressant mechanism of traditional Chinese medicines: A case study of Xiaoyaosan.
Lv M; Wang Y; Qu P; Li S; Yu Z; Qin X; Liu X
J Ethnopharmacol; 2021 Aug; 276():114167. PubMed ID: 33984458
[TBL] [Abstract][Full Text] [Related]
6. Effects of Xiaoyaosan on Depressive-Like Behaviors in Rats With Chronic Unpredictable Mild Stress Through HPA Axis Induced Astrocytic Activities.
Song M; Zhang J; Li X; Liu Y; Wang T; Yan Z; Chen J
Front Psychiatry; 2020; 11():545823. PubMed ID: 33192662
[TBL] [Abstract][Full Text] [Related]
7. Brain metabonomics study of the antidepressant-like effect of Xiaoyaosan on the CUMS-depression rats by
Liu X; Zheng X; Du G; Li Z; Qin X
J Ethnopharmacol; 2019 May; 235():141-154. PubMed ID: 30708033
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study on the diversity of butyrate-producing bacteria in response to the treatment of depression with Xiaoyaosan.
Xiong LL; Mao ML; Shu QL
Lett Appl Microbiol; 2022 Oct; 75(4):844-856. PubMed ID: 35575477
[TBL] [Abstract][Full Text] [Related]
9. A whole transcriptome profiling analysis for antidepressant mechanism of Xiaoyaosan mediated synapse loss via BDNF/trkB/PI3K signal axis in CUMS rats.
Meng P; Zhang X; Liu TT; Liu J; Luo Y; Xie MX; Yang H; Fang R; Guo DW; Zhong ZY; Wang YH; Ge JW
BMC Complement Med Ther; 2023 Jun; 23(1):198. PubMed ID: 37322430
[TBL] [Abstract][Full Text] [Related]
10. A unique insight for Xiaoyao San exerts antidepressant effects by modulating hippocampal glucose catabolism using stable isotope-resolved metabolomics.
Wu WZ; Ling-Hu T; Zhao YH; Zhao WD; Ji C; Tian JS; Ren Y; Qin XM
J Ethnopharmacol; 2023 Jan; 300():115702. PubMed ID: 36099982
[TBL] [Abstract][Full Text] [Related]
11. Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
Gao X; Zheng X; Li Z; Zhou Y; Sun H; Zhang L; Guo X; Du G; Qin X
J Ethnopharmacol; 2011 Sep; 137(1):690-9. PubMed ID: 21718771
[TBL] [Abstract][Full Text] [Related]
12. Effects of Refined Xiaoyaosan on Depressive-Like Behaviors in Rats with Chronic Unpredictable Mild Stress through Neurosteroids, Their Synthesis and Metabolic Enzymes.
Guo X; Qiu W; Liu Y; Zhang Y; Zhao H; Chen J
Molecules; 2017 Aug; 22(8):. PubMed ID: 28825678
[No Abstract] [Full Text] [Related]
13. An investigation of the antidepressant action of xiaoyaosan in rats using ultra performance liquid chromatography-mass spectrometry combined with metabonomics.
Gao XX; Cui J; Zheng XY; Li ZY; Choi YH; Zhou YZ; Tian JS; Xing J; Tan XJ; Du GH; Qin XM
Phytother Res; 2013 Jul; 27(7):1074-85. PubMed ID: 22975930
[TBL] [Abstract][Full Text] [Related]
14. Xiaoyaosan ameliorates depressive-like behavior and susceptibility to glucose intolerance in rat: involvement of LepR-STAT3/PI3K pathway in hypothalamic arcuate nucleus.
Qiu W; Wu Q; Zhang K; Da X; Tang K; Yuan N; Deng L; Wu M; Zhang Y; Quan J; Ma Q; Li X; Chen J
BMC Complement Med Ther; 2023 Apr; 23(1):116. PubMed ID: 37046230
[TBL] [Abstract][Full Text] [Related]
15. Hepatic metabolomics of the compatibility effect of Xiaoyaosan on CUMS-induced depression based on the TCM theory of "Treating Diseases via Regulating the Liver's Function".
Liu XJ; Liu HL; Zhao D; Wei FX; Wang YZ; Lv M; Chen SJ; Li SY; Qin XM
J Pharm Biomed Anal; 2021 Jul; 201():114123. PubMed ID: 33989991
[TBL] [Abstract][Full Text] [Related]
16. Studies on the potential link between antidepressant effect of Xiaoyao San and its pharmacological activity of hepatoprotection based on multi-platform metabolomics.
Chen C; Yin Q; Tian J; Gao X; Qin X; Du G; Zhou Y
J Ethnopharmacol; 2020 Mar; 249():112432. PubMed ID: 31790818
[TBL] [Abstract][Full Text] [Related]
17. Xiaoyaosan promotes neurotransmitter transmission and alleviates CUMS-induced depression by regulating the expression of Oct1 and Oct3 in astrocytes of the prefrontal cortex.
Wu Y; Liu L; Zhao Y; Li X; Hu J; Li H; Zhao R
J Ethnopharmacol; 2024 May; 326():117923. PubMed ID: 38367929
[TBL] [Abstract][Full Text] [Related]
18. Gut microbial diversity analysis using Illumina sequencing for functional dyspepsia with liver depression-spleen deficiency syndrome and the interventional Xiaoyaosan in a rat model.
Qiu JJ; Liu Z; Zhao P; Wang XJ; Li YC; Sui H; Owusu L; Guo HS; Cai ZX
World J Gastroenterol; 2017 Feb; 23(5):810-816. PubMed ID: 28223725
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the compatibility rules of traditional Chinese medicine prescriptions based on NMR metabolomics: A case study of Xiaoyaosan.
Liu X; Lv M; Wang Y; Zhao D; Zhao S; Li S; Qin X
J Ethnopharmacol; 2020 May; 254():112726. PubMed ID: 32135241
[TBL] [Abstract][Full Text] [Related]
20. Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy.
Liu XJ; Zhou YZ; Li ZF; Cui J; Li ZY; Gao XX; Sun HF; Zhang LZ; Du GH; Qin XM
J Pharm Pharmacol; 2012 Apr; 64(4):578-88. PubMed ID: 22420663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
